CANCER OF OVARY
Clinical trials for CANCER OF OVARY explained in plain language.
Never miss a new study
Get alerted when new CANCER OF OVARY trials appear
Sign up with your email to follow new studies for CANCER OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other cancer drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The trial was stopp…
Matched conditions: CANCER OF OVARY
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Promising cancer drug trial halted early: what it means for patients
Disease control TerminatedThis study tested a drug called Promitil in people with ovarian or pancreatic cancer that has specific gene mutations (BRCA or HRD) and has stopped responding to first treatment. The goal was to see if the drug could slow cancer growth and be safe. The study was stopped early, so…
Matched conditions: CANCER OF OVARY
Phase: PHASE2 • Sponsor: Lipomedix Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC